Leaflet NARATRIPTAN MYLAN 2.5mg film-coated tablets
Indicated for: migraine
Route of administration: oral
Substance: naratriptan (serotonin agonist antimigraine)
ATC: N02CC02 (Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Naratriptan is a medication used for the treatment of acute migraine, with or without aura. It belongs to the class of serotonin receptor agonists (triptans) and works by constricting dilated blood vessels in the brain, reducing pain and other migraine-associated symptoms.
The medication is taken orally, usually in tablet form, and is effective in providing rapid relief from migraine symptoms. It is intended for occasional use and should not be used for migraine prevention.
Side effects may include nausea, dizziness, fatigue, or a sensation of pressure in the chest. In rare cases, severe reactions such as high blood pressure or cardiac ischemia may occur.
Consult your doctor before use, especially if you have cardiovascular conditions or are taking other medications. Use Naratriptan as directed to avoid complications.
General data about NARATRIPTAN MYLAN 2.5mg
- Substance: naratriptan
- Date of latest medicines list: 01-07-2013
- Product code: W58318001
- Concentration: 2.5mg
- Pharmaceutical form: film-coated tablets
- Quantity: 2
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.